Tenoxicam-induced Fixed Drug Eruption Confirmed by Patch Testing

Akin Cakici O., UZUNÇAKMAK T. K., SALMAN A.

Asthma Allergy Immunology, cilt.23, sa.2, ss.180-182, 2025 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 2
  • Basım Tarihi: 2025
  • Doi Numarası: 10.21911/aai.2025.729
  • Dergi Adı: Asthma Allergy Immunology
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.180-182
  • Anahtar Kelimeler: Fixed drug eruption, patch testing, tenoxicam
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Tenoxicam has been associated with cutaneous adverse reactions, and it is categorized as a non-steroidal anti-inflammatory drug (NSAID) within the oxicam class. Herein, we report a patient with tenoxicam-induced fixed drug eruption (FDE) confirmed with patch testing. FDE is a delayed type hypersensitivity reaction frequently caused by antimicrobials and NSAIDs. Cross-reactivity may occur among the oxicams, and alternative medications should be carefully selected. This report highlights the importance of patch testing in identifying the causal drug in FDE, and the rise in awareness of tenoxicam as a potential trigger.